UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Aigen Investment Management LP

Key Points

• Aigen Investment Management LP increased its stake in UnitedHealth Group by 350.3% in the first quarter, now holding 8,420 shares valued at approximately $4.41 million.
• UnitedHealth Group recently declared a quarterly dividend of $2.21 per share, up from the previous $2.10, representing a yield of 3.5%.
• Analysts have mixed opinions on the stock, with three recommending a sell, seven a hold, and fifteen a buy, leading to a current consensus rating of "Hold" with a target price of around $366.52.

Aigen Investment Management LP raised its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 350.3% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,420 shares of the healthcare conglomerate's stock after buying an additional 6,550 shares during the quarter. UnitedHealth Group accounts for 0.7% of Aigen Investment Management LP's holdings, making the stock its 10th biggest holding. Aigen Investment Management LP's holdings in UnitedHealth Group were worth $4,410,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Citizens National Bank Trust Department increased its stake in UnitedHealth Group by 1.0% in the 1st quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate's stock worth $9,368,000 after acquiring an additional 170 shares during the last quarter. Fort Washington Investment Advisors Inc. OH boosted its stake in UnitedHealth Group by 0.3% during the 1st quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate's stock valued at $277,641,000 after purchasing an additional 1,465 shares during the last quarter. Sherbrooke Park Advisers LLC bought a new position in UnitedHealth Group in the 4th quarter worth $515,000. Full Sail Capital LLC increased its holdings in shares of UnitedHealth Group by 2.1% in the fourth quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate's stock worth $815,000 after purchasing an additional 33 shares during the last quarter. Finally, Soros Fund Management LLC purchased a new position in UnitedHealth Group in the fourth quarter worth about $39,413,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other UnitedHealth Group news, CEO Stephen J. Hemsley bought 86,700 shares of the business's stock in a transaction on Friday, May 16th. The shares were bought at an average cost of $288.57 per share, for a total transaction of $25,019,019.00. Following the transaction, the chief executive officer owned 679,493 shares in the company, valued at approximately $196,081,295.01. This trade represents a 14.63% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CFO John F. Rex purchased 17,175 shares of the business's stock in a transaction that occurred on Friday, May 16th. The stock was purchased at an average price of $291.12 per share, for a total transaction of $4,999,986.00. Following the completion of the transaction, the chief financial officer directly owned 203,796 shares in the company, valued at $59,329,091.52. This trade represents a 9.20% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have purchased 109,408 shares of company stock worth $31,607,768 in the last quarter. 0.28% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on UNH shares. Wolfe Research reduced their price objective on shares of UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a research note on Tuesday, May 20th. UBS Group restated a "buy" rating on shares of UnitedHealth Group in a report on Thursday, July 17th. HSBC reissued a "reduce" rating and issued a $270.00 price target (down previously from $490.00) on shares of UnitedHealth Group in a research report on Wednesday, May 21st. JPMorgan Chase & Co. dropped their price objective on shares of UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating on the stock in a research note on Wednesday. Finally, TD Securities reissued a "hold" rating and set a $308.00 price objective (down previously from $520.00) on shares of UnitedHealth Group in a report on Monday, May 19th. Three analysts have rated the stock with a sell rating, seven have issued a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat, UnitedHealth Group has an average rating of "Hold" and an average price target of $366.52.

UnitedHealth Group Trading Up 2.5%

Shares of UnitedHealth Group stock traded up $6.07 during trading on Friday, hitting $250.74. The stock had a trading volume of 10,146,688 shares, compared to its average volume of 18,423,422. The stock has a 50 day simple moving average of $291.78 and a 200 day simple moving average of $405.18. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73. The company has a market capitalization of $227.46 billion, a PE ratio of 10.86, a P/E/G ratio of 1.62 and a beta of 0.43. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. UnitedHealth Group's revenue for the quarter was up 12.9% compared to the same quarter last year. During the same quarter in the previous year, the company earned $6.80 earnings per share. On average, research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were issued a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 3.5%. The ex-dividend date of this dividend was Monday, June 16th. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's payout ratio is currently 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.